USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GLYCOBAC, LLC
Address:
1938 Harney St
LARAMIE, WY 82072-3037
Phone:
(307) 766-4282
URL:
EIN:
145277564
DUNS:
968784103
Number of Employees:
1
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $972,443.00 3

Award List:

A Novel Adherence Technology for Ophthalmic Medications

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$599,241.00
Agency:
HHS
Principal Investigator:
Christoph Geisler – 307-340-1616
Abstract:
DESCRIPTION: Most human therapeutic glycoproteins (biologics) are manufactured using mammalian cell lines that can add the human-type glycans required for their clinical efficacy. However, mammalian cells have some serious disadvantages - it takes a longtime to establish production lines, they can… More

Glycoengineered baculoviruses for the production of more efficacious influenza va

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$225,000.00
Agency:
HHS
Principal Investigator:
Ajaykumar Maghodia – 307-760-8194
Abstract:
DESCRIPTION (provided by applicant): Vaccination significantly reduces morbidity and mortality caused by annual influenza epidemics. Traditionally, influenza vaccines have been manufactured using adapted influenza virus grown in eggs. However, this methodsuffers from inherent disadvantages such as… More

Engineering cells for concurrent protein drug biosynthesis and polysialylation

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$148,202.00
Agency:
HHS
Principal Investigator:
Christoph Geisler – 307-340-1616
Abstract:
Project Summary / Abstract Therapeutic proteins, or biologics, represent a 100 billion market that includes drugs such as antibodies, hormones, and many others. The clinical efficacy of biologics is critically determined by their circulating half-lives.Hence, various methods have been developed to… More